Help Us Combat Abortion Stigma In Primary Care Today!
This Contraceptive Pearl covers Depo SubQ, the version of depot medroxyprogesterone acetate (DMPA) that can be prescribed as a subcutaneous injection that patients give themselves at home. It contains about 30% less progestin than the in-office form, which may reduce some of Depo’s side effects.
People with physical disabilities often lack basic reproductive health care. This Contraceptive Pearl describes how providers can go beyond compliance with the Americans with Disabilities Act towards full accessibility for patients with impaired mobility.
In this Contraceptive Pearl, options of contraception for women who have experienced abnormal pap smears are detailed.
For many years, clinicians and patients were concerned that hormonal contraceptives might raise the risk of developing breast cancer. Fortunately, studies indicate that using hormonal contraception does not contribute to breast cancer. This Contraceptive Pearl details the history and relationship between hormonal contraceptives and breast cancer.
Endometriosis varies greatly between patients. This Contraceptive Pearl explains how multiple different types of contraceptives can work as treatments for endometriosis.
A new “one size fits most” diaphragm, Caya, was approved by the FDA in September 2014 and is now available in the US. Find out about the new diaphragm in this Contraceptive Pearl.
All patients deserve to be treated with the highest level of respect. When a patient is a member of the LGBT community, health care providers should take care to use the correct language so that the patient feels most comfortable.
Nearly 60% of women aged 15-44 in the United States have used withdrawal for birth control at least once. This contraceptive Pearl covers the pros and cons of this contraceptive method.
After an abortion, women may start ovulating very soon. This is why it is so important to be prompt with contraception. This Contraceptive Pearl focuses on use of the vaginal ring after an abortion.
Liletta, a new progestin intrauterine device (IUD), was approved by the FDA in February 2015. It is the same size and shape as the Mirena and contains the same dose of levonorgestrel. Learn more about Liletta by reading this edition of the Contraceptive Pearls.
Your gift allows us to mobilize, train, and support clinicians across the country to provide reproductive health care.